Cargando…

Adverse Cardiovascular Effects of Anti-COVID-19 Drugs

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 infection is the cause of the ongoing global pandemic. Mortality from COVID-19 infection is particularly high in patients with cardiovascular diseases. In addition, COVID-19 patients with preexisting cardiovascular comorbiditie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Dongling, Zeng, Xiang, Ding, Zufeng, Lv, Fenghua, Mehta, Jawahar L., Wang, Xianwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424204/ https://www.ncbi.nlm.nih.gov/pubmed/34512335 http://dx.doi.org/10.3389/fphar.2021.699949

Ejemplares similares

Inflammation, Autophagy, and Apoptosis After Myocardial Infarction
por: Wang, Xianwei, et al.
Publicado: (2018)

Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis
por: Ding, Zufeng, et al.
Publicado: (2013)

Gene and MicroRNA Transcriptional Signatures of Angiotensin II in Endothelial Cells
por: Mehta, Jawahar L., et al.
Publicado: (2015)

Cardiovascular adverse effects associated with the use of anti-HER2 in breast cancer treatment
por: Valente, Patricia Marques Soares, et al.
Publicado: (2023)

Concentration polarization of ox-LDL activates autophagy and apoptosis via regulating LOX-1expression
por: Ding, Zufeng, et al.
Publicado: (2013)

Adverse drug events in the prevention and treatment of COVID-19: A data mining study on the FDA adverse event reporting system
por: Guo, Qiang, et al.
Publicado: (2022)

Molecular Mechanisms of Action of Emodin: As an Anti-Cardiovascular Disease Drug
por: Li, Qianqian, et al.
Publicado: (2020)

Large Impact of Low Concentration Oxidized LDL on Angiogenic Potential of Human Endothelial Cells: A Microarray Study
por: Khaidakov, Magomed, et al.
Publicado: (2012)

NLRP3 inflammasome via IL-1β regulates PCSK9 secretion
por: Ding, Zufeng, et al.
Publicado: (2020)

NLRP3 inflammasome via IL-1β regulates PCSK9 secretion: Erratum
por: Ding, Zufeng, et al.
Publicado: (2022)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases
por: Wang, Xiaoping, et al.
Publicado: (2022)

Adverse Cardiovascular Effects of Phenylephrine Eye Drops Combined With Intravenous Atropine
por: Li, Qingyu, et al.
Publicado: (2021)

A systematic review on sex differences in adverse drug reactions related to psychotropic, cardiovascular, and analgesic medications
por: Shan, Yuting, et al.
Publicado: (2023)

Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
por: Pauli, Christopher S., et al.
Publicado: (2020)

Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system
por: Jeong, Eugene, et al.
Publicado: (2022)

Adverse drug reactions and correlations with drug–drug interactions: A retrospective study of reports from 2011 to 2020
por: Jiang, Huaqiao, et al.
Publicado: (2022)

Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug
por: Uckun, Fatih M., et al.
Publicado: (2021)

Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
por: Sessa, Maurizio, et al.
Publicado: (2017)

The Adverse Cardiovascular Effects and Cardiotoxicity of Kratom (Mitragyna speciosa Korth.): A Comprehensive Review
por: Leong Bin Abdullah, Mohammad Farris Iman, et al.
Publicado: (2021)

Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs
por: Shen, Hao, et al.
Publicado: (2022)

LOX-1 Deletion Attenuates Myocardial Fibrosis in the Aged Mice, Particularly Those With Hypertension
por: Li, Xiao, et al.
Publicado: (2021)

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
por: Jiao, Xue-Feng, et al.
Publicado: (2023)

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
por: Katsuno, Hayato, et al.
Publicado: (2021)

Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions
por: Manson, Lisanne E. N., et al.
Publicado: (2022)

Mechanism and Potential Target of Blood-Activating Chinese Botanical Drugs Combined With Anti-Platelet Drugs: Prevention and Treatment of Atherosclerotic Cardiovascular Diseases
por: Li, Dan, et al.
Publicado: (2022)

Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second- and third-generation drug-eluting stents
por: Bibi, Salma, et al.
Publicado: (2022)

Immune-related adverse events of biological immunotherapies used in COVID-19
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022)

Variation in adverse drug events of opioids in the United States
por: Liu, Edward Y., et al.
Publicado: (2023)

Structural Insights Into the High Selectivity of the Anti-Diabetic Drug Mitiglinide
por: Wang, Mengmeng, et al.
Publicado: (2022)

Pro-Senescence and Anti-Senescence Mechanisms of Cardiovascular Aging: Cardiac MicroRNA Regulation of Longevity Drug-Induced Autophagy
por: Pulakat, Lakshmi, et al.
Publicado: (2020)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2022)

Pharmacists’ experiences on adverse drug reaction: 10 years later
por: Karuppannan, Mahmathi, et al.
Publicado: (2022)

Metabonomic analysis of the anti-hepatic fibrosis effect of Ganlong capsules
por: Lv, ChangLing, et al.
Publicado: (2023)

Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients
por: Cahir, Caitriona, et al.
Publicado: (2023)

Adverse effects, pharmacological interactions, and cardiovascular drugs in COVID-19 treatment
por: Chuquiure-Valenzuela, Eduardo, et al.
Publicado: (2021)

Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database
por: Magro, Lara, et al.
Publicado: (2021)

Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
por: Ma, Pan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6etmu9grm53lc6f472ddul94sg